1887

Abstract

Hepatitis C virus (HCV) core plays a key role in viral particle formation and is involved in viral pathogenesis. Here, constructs for single-domain intrabodies consisting of variable regions derived from mouse mAbs against HCV core were established. Expressed single-domain intrabodies were shown to bind to HCV core, and inhibit the growth of cell culture-produced HCV derived from JFH-1 (genotype 2a) and a TH (genotype 1b)/JFH-1 chimera. Adenovirus vectors expressing intrabodies were also capable of reducing HCV propagation. Intrabody expression did not affect viral entry or genome replication of single-round infectious -complemented HCV particles. However, intrabody expression reduced intracellular and extracellular infectious titres in CD81-defective Huh7-25 cells transfected with the HCV genome, suggesting that these intrabodies impair HCV assembly. Furthermore, intrabody expression suppressed HCV core-induced NFκB promoter activity. These intrabodies may therefore serve as tools for elucidating the role of core in HCV pathogenesis.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000423
2016-04-01
2019-12-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/4/887.html?itemId=/content/journal/jgv/10.1099/jgv.0.000423&mimeType=html&fmt=ahah

References

  1. Akazawa D., Date T., Morikawa K., Murayama A., Miyamoto M., Kaga M., Barth H., Baumert T. F., Dubuisson J., Wakita T.. 2007; CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol81:5036–5045 [CrossRef][PubMed]
    [Google Scholar]
  2. Corte-Real S., Collins C., Aires da Silva F., Simas J. P., Barbas C. F. III, Chang Y., Moore P., Goncalves J.. 2005; Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. Blood106:3797–3802 [CrossRef][PubMed]
    [Google Scholar]
  3. Counihan N. A., Rawlinson S. M., Lindenbach B. D.. 2011; Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog7:e1002302 [CrossRef][PubMed]
    [Google Scholar]
  4. Fukuda H., Terashima M., Koshikawa M., Kanegae Y., Saito I.. 2006; Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends. Microbiol Immunol50:643–654 [CrossRef][PubMed]
    [Google Scholar]
  5. Gal-Tanamy M., Zemel R., Bachmatov L., Jangra R. K., Shapira A., Villanueva R. A., Yi M., Lemon S. M., Benhar I., Tur-Kaspa R.. 2010; Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. Antiviral Res88:95–106 [CrossRef][PubMed]
    [Google Scholar]
  6. Greenberg A. S., Avila D., Hughes M., Hughes A., McKinney E. C., Flajnik M. F.. 1995; A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature374:168–173 [CrossRef][PubMed]
    [Google Scholar]
  7. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E. B., Bendahman N., Hammers R.. 1993; Naturally occurring antibodies devoid of light chains. Nature363:446–448 [CrossRef][PubMed]
    [Google Scholar]
  8. Harmsen M. M., De Haard H. J.. 2007; Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol77:13–22 [CrossRef][PubMed]
    [Google Scholar]
  9. Lai M. M. C., Ware C. F.. 2000; Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol242:117–134
    [Google Scholar]
  10. Lavanchy D.. 2011; Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect17:107–115 [CrossRef][PubMed]
    [Google Scholar]
  11. Mann E. A., Stanford S., Sherman K. E.. 2006; Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Res121:51–57 [CrossRef][PubMed]
    [Google Scholar]
  12. Marasco W. A., Haseltine W. A., Chen S. Y.. 1993; Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc Natl Acad Sci U S A90:7889–7893 [CrossRef][PubMed]
    [Google Scholar]
  13. Marusawa H., Hijikata M., Chiba T., Shimotohno K.. 1999; Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol73:4713–4720[PubMed]
    [Google Scholar]
  14. Masaki T., Suzuki R., Murakami K., Aizaki H., Ishii K., Murayama A., Date T., Matsuura Y., Miyamura T., other authors. 2008; Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol82:7964–7976 [CrossRef][PubMed]
    [Google Scholar]
  15. Masaki T., Suzuki R., Saeed M., Mori K., Matsuda M., Aizaki H., Ishii K., Maki N., Miyamura T., other authors. 2010; Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol84:5824–5835 [CrossRef][PubMed]
    [Google Scholar]
  16. Ray R. B., Ray R.. 2001; Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Lett202:149–156 [CrossRef][PubMed]
    [Google Scholar]
  17. Saeed M., Suzuki R., Kondo M., Aizaki H., Kato T., Mizuochi T., Wakita T., Watanabe H., Suzuki T.. 2009; Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes. J Clin Microbiol47:4141–4143 [CrossRef][PubMed]
    [Google Scholar]
  18. Sato M., Sawahata R., Sakuma C., Takenouchi T., Kitani H.. 2013; Single domain intrabodies against WASP inhibit TCR-induced immune responses in transgenic mice T cells. Sci Rep3:3003 [CrossRef][PubMed]
    [Google Scholar]
  19. Suzuki R., Saito K., Kato T., Shirakura M., Akazawa D., Ishii K., Aizaki H., Kanegae Y., Matsuura Y., other authors. 2012; Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology432:29–38 [CrossRef][PubMed]
    [Google Scholar]
  20. Tanaka T., Williams R. L., Rabbitts T. H.. 2007; Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. EMBO J26:3250–3259 [CrossRef][PubMed]
    [Google Scholar]
  21. Yamamoto M., Hayashi N., Takehara T., Ueda K., Mita E., Tatsumi T., Sasaki Y., Kasahara A., Hori M.. 1999; Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Hepatology30:300–307 [CrossRef][PubMed]
    [Google Scholar]
  22. Yoshida H., Kato N., Shiratori Y., Otsuka M., Maeda S., Kato J., Omata M.. 2001; Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem276:16399–16405 [CrossRef][PubMed]
    [Google Scholar]
  23. You L. R., Chen C. M., Lee Y. H.. 1999; Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol73:1672–1681[PubMed]
    [Google Scholar]
  24. Zhang J., Rabbitts T. H.. 2014; Intracellular antibody capture: a molecular biology approach to inhibitors of protein-protein interactions. Biochim Biophys Acta1844:1970–1976 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000423
Loading
/content/journal/jgv/10.1099/jgv.0.000423
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error